| Hans-Günter Meyer-Thompson | Buprenorphin
Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study.
Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study.
Parkin S, Neale J, Strang J.
Int J Drug Policy. 2023 Oct 19;122:104221. doi: 10.1016/j.drugpo.2023.104221. Epub ahead of print. PMID: 37865052.
https://www.sciencedirect.com/science/article/pii/S0955395923002682